Grail and Epic announced a collaboration that will integrate the Galleri multi-cancer early detection test directly into Epic electronic health record workflows. Clinicians using Epic will be able to access the Galleri test within their native EHR environment, order at the point of care, and receive results through existing clinical and patient portal systems. The company said the rollout is intended to remove operational friction that can slow adoption, and that it will allow around 450 health systems to access Galleri results through standard EHR interfaces. Epic integration planning begins in 1Q26, with broader ordering and results availability targeted by the end of 2026. Grail President Josh Ofman tied the initiative to earlier detection aims, while the companies did not disclose financial terms. The integration follows earlier EHR-related connectivity announcements with other platforms, including Athenahealth and Quest Diagnostics add-ons reported previously.